Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

The value of a project like HARMONY

HARMONY Alliance: 3rd General Assembly for Partners and Associated Members

Published: 26 Nov 2018

Views: 1022

Rating:

Save

Tom Marshall - AbbVie, USA, HARMONY Partner

Tom Marshall speaks with ecancer at the HARMONY Project general assembly 2018 in Valencia.

He describes the importance of HARMONY from an outcomes researcher's perspective.

To see more from HARMONY visit their website.

Related Videos

Synthetic biology and precision medicine in blood and gynaecological cancers

Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria...

Synthetic biology and precision medicine in blood and gynaecological cancers ( Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa )

OncoAlert Round Up for September 15-21, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

The Vietnam National Cancer Institute’s efforts in improving cancer care in...

Dr Thanh Huong Tran Thi - Director, Vietnam National Cancer Institute

The Vietnam National Cancer Institute’s efforts in improving cancer care in Vietnam ( Dr Thanh Huong Tran Thi - Director, Vietnam National Cancer Institute )

The Southeast Asian Breast Cancer Symposium; background, aims and successes

Carolyn Taylor - Executive Director, Global Focus on Cancer

The Southeast Asian Breast Cancer Symposium; background, aims and successes ( Carolyn Taylor - Executive Director, Global Focus on Cancer )

OncoAlert Round Up for August 25th - 31st, 2023

Dr Gil Morgan - Executive Director, OncoAlert

OncoAlert Round Up for August 25th - 31st, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )

Latest in immunological technologies that can treat, control, and prevent cancer

Dr Jill O’Donnell-Tormey - Chief Executive Officer, Cancer Research Institute

Latest in immunological technologies that can treat, control, and prevent cancer ( Dr Jill O’Donnell-Tormey - Chief Executive Officer, Cancer Research Institute )

The role of provider assumptions in decreasing access to care in the LGBTQ...

Dr Narjust Flores - Dana-Farber Cancer Institute, Boston, USA

The role of provider assumptions in decreasing access to care in the LGBTQ community ( Dr Narjust Flores - Dana-Farber Cancer Institute, Boston, USA )

ASCO's efforts to improve global cancer care through the years

Dr Carlos Santiago Vallejos Sologuren - Oncosalud, Lima, Peru

ASCO's efforts to improve global cancer care through the years ( Dr Carlos Santiago Vallejos Sologuren - Oncosalud, Lima, Peru )

ALLO-316 demonstrates encouraging anti-tumour activity for patients with...

Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA

ALLO-316 demonstrates encouraging anti-tumour activity for patients with advanced or metastatic ccRCC ( Dr Samer Srour - The University of Texas MD Anderson Cancer Center, Houston, USA )

More from ecancer